Association of Hypoglycemia with Biomarkers of Oxidative Stress and Antioxidants: An Observational Study

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

Oxidative stress (OS) plays a pivotal role in the pathogenesis of insulin resistance (IR), particularly in its association with obesity. This study evaluate both the diagnostic and clinical significance of assessing oxidative status in patients affected by overweight and obesity displaying IR, especially with reactive hypoglycemic episodes (RH). A comprehensive examination of OS biomarkers was carried out, encompassing measurements of total oxidative capacity (TOC) and total antioxidant capacity (TAC). Our analysis results reveal noteworthy connections between OS levels and the severity of IR in overweight and obese patients. Moreover, in the study, we demonstrated the diagnostic utility of serum concentrations of TAC and TOC as indicators of the risk of RH, the occurrence of which, even at the stage of overweight, may be associated with increased OS and further development of obesity. Our findings imply that the evaluation of oxidative status could serve as a crucial diagnostic and prognostic tool for patients observed with IR and overweight and obesity. In conclusion, our study underscores the potential utility of assessing oxidative status in the context of IR and highlights the possibility of identifying novel therapeutic targets for the treatment of overweight and obese patients.

Comparative analysis of antioxidant status in diabetic patients with and without insulin resistance

Diabetes mellitus (DM) is a metabolic disorder characterized by insulin resistance, where hyperglycemia is believed to trigger oxidative stress, contributing to insulin function impairment. This study aimed to assess and compare levels of malondialdehyde (MDA), glutathione (GSH), and uric acid in diabetic patients with and without insulin resistance and to assess the correlation with fasting blood sugar (FBS) and lipid profiles. Significant variations were found in MDA, uric acid, and GSH levels between insulin-resistant and non-resistant diabetic groups (p<0.0001). FBS, hemoglobin A1C (HbA1C), insulin activity, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) significantly differed between the groups (p<0.0001). Total cholesterol, triglyceride, high-density lipoprotein (HDL), very-low-density lipoprotein (VLDL), and low-density lipoprotein-cholesterol (LDL-C) concentrations were higher in the insulin resistance group than the non-insulin resistance group (p<0.0001). Uric acid also exhibited a significant correlation (p<0.01) with LDL levels, while HDL levels showed a negative correlation with both MDA and uric acid (p<0.001). Diabetes mellitus, characterized by chronic hyperglycemia, may play a role in the development of oxidative stress. This oxidative stress is a significant factor that could potentially lead to the onset of insulin resistance, a condition strongly associated with dyslipidemia. The results of this study indicate that the decrease in GSH levels and the increase in MDA and uric acid levels are particularly noteworthy in the context of insulin resistance among patients with diabetes.